Related Experiment Videos
Optimizing factor prophylaxis for the haemophilia population: where do we stand?
V S Blanchette1, M Manco-Johnson, E Santagostino
1Division of Hematology/Oncology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Canada. victor.blanchette@sickkids.ca
Summary
Early factor prophylaxis prevents joint damage in severe hemophilia (A and B) patients. Modified regimens offer effective treatment with fewer complications, improving musculoskeletal health in children.
Area of Science:
- Hematology
- Pediatric Orthopedics
- Pharmacology
Background:
- Severe hemophilia (Factor VIII or IX < 1%) causes recurrent bleeding, leading to disabling arthritis, especially in those without consistent therapy or with inhibitors.
- Musculoskeletal complications in children with severe hemophilia can be prevented by early, long-term factor prophylaxis.
- Primary prophylaxis, initiated before joint damage, is crucial for optimal musculoskeletal outcomes.
Purpose of the Study:
- To review the principles and evolution of primary prophylaxis for severe hemophilia.
- To discuss modified prophylaxis regimens and their impact on venous access and complications.
- To highlight the ongoing challenges of compliance and the need for further research.
Main Methods:
- Review of the established Malmo protocol (FVIII 20-40 IU/kg alternate days; FIX 20-40 IU/kg twice weekly).
- Analysis of modified prophylaxis strategies, including once-weekly infusions and bleeding-frequency-based escalation.
- Consideration of venous access methods (peripheral veins, central venous access devices, arteriovenous fistulae) and associated risks.
Main Results:
- Modified prophylaxis regimens can be implemented effectively in young children, often avoiding central venous access devices and associated complications.
- Alternative venous access strategies like arteriovenous fistulae are being explored for reliable access.
- Challenges remain regarding patient compliance and determining the optimal duration of prophylaxis.
Conclusions:
- Early primary prophylaxis is essential for preventing joint damage in severe hemophilia.
- Modified prophylaxis protocols offer a feasible and safer alternative in many cases, particularly in resource-rich settings.
- Further prospective studies are needed to address compliance and long-term outcomes, including quality of life and economic impact.